EODData

NASDAQ, XENE: Xenon Pharmaceuticals Inc

07 Nov 25 15:59
LAST:

38.25

CHANGE:
 0.05
OPEN:
38.60
HIGH:
38.60
ASK:
3.05
VOLUME:
226.2K
CHG(%):
0.13
PREV:
38.30
LOW:
37.23
BID:
2.40
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2538.2838.4137.2338.25475.3K
06 Nov 2538.6339.4137.6838.30586.9K
05 Nov 2538.8439.2237.8738.661.1M
04 Nov 2539.7440.4537.6339.091.44M
03 Nov 2541.6041.7040.1341.121.11M
31 Oct 2542.2642.7241.4541.92766.0K
30 Oct 2541.8542.9641.8542.67726.3K
29 Oct 2542.2542.7741.4442.30749.1K
28 Oct 2541.7842.7441.4142.53699.7K
27 Oct 2540.7943.3340.7941.89975.5K

COMPANY PROFILE

Name:Xenon Pharmaceuticals Inc
About:Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
Website:https://www.xenon-pharma.com
CUSIP:98420N105
CIK:0001582313
ISIN:CA98420N1050
FIGI:BBG0073DM784

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-13.66 
Forward P/E:-11.55 
PEG Ratio:-0.32 
Price to Sales:422.75 
Price to Book:4.99 
Operating Margin:-42.42 
Return on Assets:-0.26 
Return on Equity:-0.38 
EPS Ratio:-3.55 
Revenue:7.5M 
Shares:77.11M 
Market Cap:2.949B 

TECHNICAL INDICATORS

MA5:39.082.2%
MA10:40.676.3%
MA20:41.187.7%
MA50:39.393.0%
MA100:36.504.8%
MA200:35.617.4%
RSI14:22.60 
WPR14:-100.00 
MTM14:-4.79
ROC14:-0.11 
ATR:1.61 
Week High:42.7211.7%
Week Low:37.232.7%
Month High:44.2315.6%
Month Low:37.237.4%
Year High:46.0020.3%
Year Low:26.7443.0%
Volatility:24.60